FDA proposes GRAS notification rule with streamlined path

FDA’s proposed GRAS notification rule would end self-affirmations, create a streamlined option for legacy ingredients, and likely face legal tests, experts say.

FDA’s proposed GRAS notification rule would end self-affirmations, create a streamlined option for legacy ingredients, and likely face legal tests, experts say.